Clinical Trials
2 trialsNCT07471815 2026-03-13
Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
Harbin Medical University
Phase 2 Active not recruiting
NCT03861091 2023-07-27
Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT
Wake Forest University Health Sciences
Phase 2 Completed